Tag: biopharma
Indian pharma firms set for 7–9% revenue growth in FY26 despite...
ICRA maintains a stable outlook on the pharmaceuticals sector, supported by sustained demand in both domestic and export markets
Premas Biotech wins Gates Foundation grant to advance thermostable rabies vaccine
Funding to support early-stage development of innovative rabies vaccine for low- and middle-income countries
Top 20 global biopharma companies report 5.7% fall in market capitalization...
Tariffs, pricing pressures erode $200 billion in value for top biopharma firms; Alnylam and Novartis buck the trend with strong gains
Aurigene unveils CHEESE database to speed up hit identification
New virtual library on CHEESE platform streamlines hit identification and boosts self-reliance in drug discovery
Takeda India launches ‘For You, With You IBD’ app to support...
New patient services initiative aims to empower more than a million IBD patients in India through tracking, education and daily support tools
Thermo Fisher Scientific announces crucial investments in India at Biopharma Conclave...
Advanced facilities in Hyderabad will provide technology access, skill-building
Agilent supports India’s global biopharma ambitions with State-of-the-Art Experience Center in...
The new Agilent Biopharma Experience Center in Hyderabad presents a major opportunity to accelerate the city’s leadership in life sciences and healthcare innovation
Lost in Translation? India’s Biologics R&D Shortfall
Domestic manufacturers have petitioned for tax reliefs—such as income‑tax exemptions on new molecular entities—to incentivize high‑risk R&D
Sun Pharma’s phase 3 trials of ILUMYA support potential U.S. submission...
Both pivotal studies met their primary endpoint with statistically significant improvements based on ACR20 response rates at Week 24 with tildrakizumab 100 mg (ILUMYA) compared to placebo
World Zoonosis Day 2025: Indian Immunologicals administers 1 lakh free dosages...
Nationwide vaccination camps at around 100 cities across 21 states